1. Market Research
  2. > Healthcare
  3. > Medical Supply Market Trends
  4. > Stratatech Corporation - Product Pipeline Analysis, 2016 Update

Summary

Stratatech Corporation (Stratatech) is a regenerative medicine company offers skin regeneration therapies. The company offers ExpressGraft genetically enhanced skin tissues and StrataGraft skin tissues. Its StrataGraft skin tissues provide mimic natural human skin, with both dermal and fully differentiated epidermal layers that is used in severe burns and other complex skin defects. The company provides skin regeneration therapies for severe burns and other rare diseases, and chronic non-healing ulcers. Its ExpressGraft genetically enhanced skin tissues provide therapeutic proteins that offer protection and modulation of local wound microenvironment, fight infection, and accelerate healing. Stratatech is headquartered in Madison, Wisconsin, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Stratatech Corporation
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Table Of Contents

Stratatech Corporation - Product Pipeline Analysis, 2016 Update
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Stratatech Corporation Company Snapshot 6
Stratatech Corporation Company Overview 6
Key Information 6
Stratatech Corporation Pipeline Products and Clinical Trials Overview 7
Stratatech Corporation - Major Products and Services 9
Stratatech Corporation Pipeline Products by Development Stage 10
Stratatech Corporation Pipeline Products Overview 12
EpiReady 12
EpiReady Product Overview 12
ExpressGraft - Antineoplastic 13
ExpressGraft - Antineoplastic Product Overview 13
ExpressGraft - Sclerotic Digital Ulcers 14
ExpressGraft - Sclerotic Digital Ulcers Product Overview 14
ExpressGraft Antimicrobial - Diabetic Foot Ulcers 15
ExpressGraft Antimicrobial - Diabetic Foot Ulcers Product Overview 15
ExpressGraft Antimicrobial - Venous Leg Ulcers 16
ExpressGraft Antimicrobial - Venous Leg Ulcers Product Overview 16
ExpressGraft Pro-Angeogenic - Venous Leg Ulcers 17
ExpressGraft Pro-Angeogenic - Venous Leg Ulcers Product Overview 17
ExpressGraft Pro-Angiogenic - Diabetic Foot Ulcers 18
ExpressGraft Pro-Angiogenic - Diabetic Foot Ulcers Product Overview 18
ExpressGraftEnhance Tissue 19
ExpressGraftEnhance Tissue Product Overview 19
StrataGraft - Epidermolysis Bullosa 20
StrataGraft - Epidermolysis Bullosa Product Overview 20
StrataGraft - Scar Revision 21
StrataGraft - Scar Revision Product Overview 21
StrataGraft - Scleroderma Digital Ulcers 22
StrataGraft - Scleroderma Digital Ulcers Product Overview 22
StrataGraft - Severe Burns 23
StrataGraft - Severe Burns Product Overview 23
Stratatech Corporation - Key Competitors 24
Stratatech Corporation - Key Employees 25
Stratatech Corporation - Locations And Subsidiaries 26
Head Office 26
Recent Developments 27
Stratatech Corporation, Recent Developments 27
Oct 05, 2015: Stratatech Awarded BARDA Project BioShield Contract Valued up to $247 Million for StrataGraft Skin Tissue for Thermal Burns 27
Mar 10, 2015: Stratatech Announces Positive Top-Line Results from Proof-of-Concept Study of StrataGraft Skin Tissue in Patients with Severe Burns 28
Jul 31, 2013: Stratatech Awarded BARDA Contract Valued up to $47.2 Million for Advanced Development of StrataGraft Skin Tissue for Thermal Burns 28
Jan 16, 2013: Stratatech Announces Impressive Clinical Results For StrataGraft Skin Tissue 29
Jun 13, 2012: Stratatech's StrataGraft Skin Substitute Receives FDA Orphan Drug Designation 29
Apr 27, 2012: Stratatech Reports Positive Interim Clinical Results For StrataGraft Skin Substitute 30
Sep 23, 2011: Stratatech Initiates Second Clinical Trial Of StrataGraft Skin Substitute 30
Dec 13, 2010: Stratatech Appoints Russell Smestad As president 31
Nov 16, 2010: Stratatech Receives $3.5 Million To Continue Development Of ExpressGraftEnhance Tissue 31
Jan 11, 2010: Stratatech To Collaborate With Fortune 200 Company On Product Development 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Stratatech Corporation, Key Facts 6
Stratatech Corporation Pipeline Products and Clinical Trials Overview 7
Stratatech Corporation Pipeline Products by Equipment Type 7
Stratatech Corporation Pipeline Products by Indication 8
Stratatech Corporation, Major Products and Services 9
Stratatech Corporation Number of Pipeline Products by Development Stage 10
Stratatech Corporation Pipeline Products Summary by Development Stage 11
EpiReady - Product Status 12
EpiReady - Product Description 12
ExpressGraft - Antineoplastic - Product Status 13
ExpressGraft - Antineoplastic - Product Description 13
ExpressGraft - Sclerotic Digital Ulcers - Product Status 14
ExpressGraft - Sclerotic Digital Ulcers - Product Description 14
ExpressGraft Antimicrobial - Diabetic Foot Ulcers - Product Status 15
ExpressGraft Antimicrobial - Diabetic Foot Ulcers - Product Description 15
ExpressGraft Antimicrobial - Venous Leg Ulcers - Product Status 16
ExpressGraft Antimicrobial - Venous Leg Ulcers - Product Description 16
ExpressGraft Pro-Angeogenic - Venous Leg Ulcers - Product Status 17
ExpressGraft Pro-Angeogenic - Venous Leg Ulcers - Product Description 17
ExpressGraft Pro-Angiogenic - Diabetic Foot Ulcers - Product Status 18
ExpressGraft Pro-Angiogenic - Diabetic Foot Ulcers - Product Description 18
ExpressGraftEnhance Tissue - Product Status 19
ExpressGraftEnhance Tissue - Product Description 19
StrataGraft - Epidermolysis Bullosa - Product Status 20
StrataGraft - Epidermolysis Bullosa - Product Description 20
StrataGraft - Scar Revision - Product Status 21
StrataGraft - Scar Revision - Product Description 21
StrataGraft - Scleroderma Digital Ulcers - Product Status 22
StrataGraft - Scleroderma Digital Ulcers - Product Description 22
StrataGraft - Severe Burns - Product Status 23
StrataGraft - Severe Burns - Product Description 23
Stratatech Corporation, Key Employees 25

List of Figures
Stratatech Corporation Pipeline Products by Equipment Type 8
Stratatech Corporation Pipeline Products by Development Stage 10

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
LifeBond Ltd. - Product Pipeline Analysis, 2016 Update

LifeBond Ltd. - Product Pipeline Analysis, 2016 Update

  • $ 750
  • Company report
  • August 2016
  • by Global Data

Summary LifeBond Ltd. (LifeBond) is a medical device company that develops medical devices for bio-surgery and tissue repair. The company’s products comprise lifeseal surgical sealant and lifemesh self-fixating ...

Wound Management Technologies, Inc. (WNDM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Wound Management Technologies, Inc. (WNDM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • September 2016
  • by Global Data

Summary Wound Management Technologies, Inc. (WMT) is a medical device company. It develops and markets advanced wound care products. The company offers its patented product CellerateRX in powder (collagen) ...

Derma Sciences, Inc. (DSCI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Derma Sciences, Inc. (DSCI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2016
  • by Global Data

Summary Derma Sciences, Inc. (Derma Sciences) is a medical. It focuses on advanced wound care and traditional wound care. Its advanced wound care product portfolio includes dermagran, silverseal, alginate ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.